Companies / RMD vs SOLV
RMD vs SOLV: ResMed and Solventum
ResMed (RMD) reported $5.7B in revenue against a 26.9% net margin, while Solventum (SOLV) reported $8.3B at a 18.7% net margin, most recently.
| Metric | RMD | SOLV |
|---|---|---|
| Revenue | $5.7B | $8.3B |
| Net Income | $1.5B | $1.6B |
| Gross Margin | 61.1% | 53.5% |
| Operating Margin | 33.4% | 26.2% |
| EPS (Diluted) | $10.43 | $8.88 |
| Free Cash Flow | $1.6B | $-10.0M |
| Total Debt | $0.7B | $5.0B |
| P/E Ratio | 18.7× | 8.9× |
| P/B Ratio | 4.3× | 2.7× |
| Stock Price | $238.83 | $87.11 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| RMD Revenue | $3.6B | $4.2B | $4.7B | $5.1B |
| SOLV Revenue | $8.1B | $8.2B | $8.3B | $8.3B |